tradingkey.logo
tradingkey.logo
検索

Procept Biorobotics Corp

PRCT
ウォッチリストに追加
21.030USD
-2.440-10.40%
終値 07/02, 13:00ET15分遅れの株価
1.20B時価総額
損失額直近12ヶ月PER

詳細情報 Procept Biorobotics Corp 企業名

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.

Procept Biorobotics Corpの企業情報

企業コードPRCT
会社名Procept Biorobotics Corp
上場日Sep 15, 2021
最高経営責任者「CEO」Wood (Larry L)
従業員数756
証券種類Ordinary Share
決算期末Sep 15
本社所在地150 Baytech Drive
都市SAN JOSE
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号95134
電話番号16502329832
ウェブサイトhttps://www.procept-biorobotics.com/
企業コードPRCT
上場日Sep 15, 2021
最高経営責任者「CEO」Wood (Larry L)

Procept Biorobotics Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.32K
-0.45%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
16.16K
+20.51%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
Thomas M. Prescott
Thomas M. Prescott
Independent Chairman of the Board
Independent Chairman of the Board
4.10K
+80.83%
Mr. Larry L. Wood
Mr. Larry L. Wood
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.20K
-9770.22%
Ms. Amy M. Dodrill
Ms. Amy M. Dodrill
Independent Director
Independent Director
--
--
Mr. Antal Desai
Mr. Antal Desai
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.32K
-0.45%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
16.16K
+20.51%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--

よくある質問

Procept Biorobotics Corpの上位5名の株主は誰ですか?

Procept Biorobotics Corpの上位5名の株主は以下のとおりです。Dr. Frederic H. (Fred) Moll, M.D.

Procept Biorobotics Corp(PRCT)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Procept Biorobotics Corpの株式を保有している機関は597社あり、保有株式の総市場価値は約65.01Mで、全体の114.22%を占めています。2025Q4と比較して、機関の持ち株は-1014187.00増加しています。

Procept Biorobotics Corpの最大の収益源は何ですか?

2026Q1において、Hand pieces and other consumables部門がProcept Biorobotics Corpにとって最大の収益を生み出しており、その金額は181.45Mで、全収益の58.90%を占めています。